Oncology

  1. Venclyxto/Venclexta (venetoclax)
    Venclyxto/Venclexta (venetoclax)
    by AbbVie Ltd
    for Leukemia
    €112.80
  2. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €6,133.20
  3. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €4,140.00
  4. Bavencio (avelumab)
    Bavencio (avelumab)
    by Merck Serono Europe Limited
    for Urothelial Carcinoma, Skin Cancer
    €1,152.00
  5. Beleodaq (belinostat)
    Beleodaq (belinostat)
    by Spectrum Pharmaceuticals, Inc.
    for Lymphoma
    €3,036.00
  6. Besponsa (inotuzumab ozogamicin)
    Besponsa (inotuzumab ozogamicin)
    by Pfizer Limited
    for Leukemia
    €12,648.00
  7. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €2,880.00
  8. Cabometyx (cabozantinib)
    Cabometyx (cabozantinib)
    by Ipsen Pharma
    for Kidney Cancer
    €5,985.00
  9. Cometriq (cabozantinib)
    Cometriq (cabozantinib)
    by Ipsen Pharma
    for Thyroid Cancer
    €5,844.00
View as Grid List

Items 10-18 of 38

per page
Set Descending Direction